AU728263B2 - Auto-deconvoluting combinatorial libraries - Google Patents

Auto-deconvoluting combinatorial libraries Download PDF

Info

Publication number
AU728263B2
AU728263B2 AU26450/97A AU2645097A AU728263B2 AU 728263 B2 AU728263 B2 AU 728263B2 AU 26450/97 A AU26450/97 A AU 26450/97A AU 2645097 A AU2645097 A AU 2645097A AU 728263 B2 AU728263 B2 AU 728263B2
Authority
AU
Australia
Prior art keywords
xaa
information
compounds
library
note
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU26450/97A
Other languages
English (en)
Other versions
AU2645097A (en
Inventor
Terance Hart
Tony Johnson
Martin Quibell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir UK Ltd
Original Assignee
Medivir UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9608457.9A external-priority patent/GB9608457D0/en
Priority claimed from GBGB9616115.3A external-priority patent/GB9616115D0/en
Priority claimed from GBGB9624584.0A external-priority patent/GB9624584D0/en
Application filed by Medivir UK Ltd filed Critical Medivir UK Ltd
Publication of AU2645097A publication Critical patent/AU2645097A/en
Assigned to MEDIVIR UK LTD reassignment MEDIVIR UK LTD Alteration of Name(s) of Applicant(s) under S113 Assignors: PEPTIDE THERAPEUTICS LIMITED
Application granted granted Critical
Publication of AU728263B2 publication Critical patent/AU728263B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00279—Features relating to reactor vessels
    • B01J2219/00306—Reactor vessels in a multiple arrangement
    • B01J2219/00313—Reactor vessels in a multiple arrangement the reactor vessels being formed by arrays of wells in blocks
    • B01J2219/00315—Microtiter plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00497—Features relating to the solid phase supports
    • B01J2219/00504—Pins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU26450/97A 1996-04-24 1997-04-24 Auto-deconvoluting combinatorial libraries Ceased AU728263B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9608457.9A GB9608457D0 (en) 1996-04-24 1996-04-24 Inhibitors of proteolytic enzymes
GB9608457 1996-04-24
GB9616115 1996-07-31
GBGB9616115.3A GB9616115D0 (en) 1996-07-31 1996-07-31 Substrate and inhibitors of proteolytic enzymes
GB9624584 1996-11-27
GBGB9624584.0A GB9624584D0 (en) 1996-11-27 1996-11-27 Substances and inhibitors of proteolytic enzymes
PCT/GB1997/001158 WO1997042216A1 (en) 1996-04-24 1997-04-24 Auto-deconvoluting combinatorial libraries

Publications (2)

Publication Number Publication Date
AU2645097A AU2645097A (en) 1997-11-26
AU728263B2 true AU728263B2 (en) 2001-01-04

Family

ID=27268257

Family Applications (2)

Application Number Title Priority Date Filing Date
AU26450/97A Ceased AU728263B2 (en) 1996-04-24 1997-04-24 Auto-deconvoluting combinatorial libraries
AU26449/97A Ceased AU706855B2 (en) 1996-04-24 1997-04-24 Substrates and inhibitors of proteolytic enzymes

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU26449/97A Ceased AU706855B2 (en) 1996-04-24 1997-04-24 Substrates and inhibitors of proteolytic enzymes

Country Status (10)

Country Link
US (2) US6528275B1 (online.php)
EP (2) EP0906334A1 (online.php)
JP (2) JP2000512979A (online.php)
AT (1) ATE203545T1 (online.php)
AU (2) AU728263B2 (online.php)
CA (2) CA2252508A1 (online.php)
DE (1) DE69705838T2 (online.php)
DK (1) DK0906333T3 (online.php)
ES (1) ES2162277T3 (online.php)
WO (2) WO1997042216A1 (online.php)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6149869A (en) * 1996-10-23 2000-11-21 Glaxo Wellcome Inc. Chemical synthesizers
US6042789A (en) * 1996-10-23 2000-03-28 Glaxo Group Limited System for parallel synthesis of organic compounds
AU744444B2 (en) * 1996-10-31 2002-02-21 Karo Bio Ab Identification of drugs using complementary combinatorial libraries
US6617114B1 (en) 1996-10-31 2003-09-09 Karo Bio Ab Identification of drug complementary combinatorial libraries
US6083761A (en) * 1996-12-02 2000-07-04 Glaxo Wellcome Inc. Method and apparatus for transferring and combining reagents
US6054325A (en) * 1996-12-02 2000-04-25 Glaxo Wellcom Inc. Method and apparatus for transferring and combining distinct chemical compositions with reagents
GB9722818D0 (en) * 1997-10-30 1997-12-24 Peptide Therapeutics Ltd A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
EP1034154A1 (en) * 1997-11-26 2000-09-13 Peptide Therapeutics Limited A solid-phase technology for the preparation of combinatorial libraries through amide-bond anchoring
US6083682A (en) 1997-12-19 2000-07-04 Glaxo Group Limited System and method for solid-phase parallel synthesis of a combinatorial collection of compounds
MY153569A (en) 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
US6569636B2 (en) * 1998-05-29 2003-05-27 Hawaii Biotechnology Group, Inc. Assay for modulators of metallo-enzyme activity
DE19925402C2 (de) * 1999-06-02 2001-12-20 Molecular Machines & Ind Gmbh Screening von Target-Ligand-Wechselwirkungen
WO2001059149A2 (en) * 2000-02-11 2001-08-16 Cellomics, Inc. Peptide biosensors for anthrax protease
JP2002250730A (ja) * 2001-02-27 2002-09-06 Shinwa Kako Kk 分子センサー及びその製造方法
MY140707A (en) 2002-02-28 2010-01-15 Mitsubishi Tanabe Pharma Corp Process for preparing a phenylalanine derivative and intermediates thereof
US7122580B2 (en) * 2002-08-09 2006-10-17 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7501538B2 (en) 2003-08-08 2009-03-10 Transtech Pharma, Inc. Aryl and heteroaryl compounds, compositions and methods of use
US7208601B2 (en) * 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
US8015064B2 (en) * 2005-04-20 2011-09-06 At&T Intellectual Property I, Lp System and method of providing advertisements to cellular devices
JP2009502158A (ja) * 2005-07-26 2009-01-29 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 酵母のストレス耐性を増加させる遺伝子類の同定方法類、およびそれらの遺伝子類の酵母株改良のための使用
US9267952B2 (en) 2008-11-05 2016-02-23 Morphosys Ag Deconvolution method
EP2366027B1 (en) * 2008-11-20 2017-01-11 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Rapid fret-based diagnosis of bacterial pathogens
EP2189536A1 (en) * 2008-11-20 2010-05-26 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Rapid FRET based anthrax diagnosis
JP2015508414A (ja) 2012-01-12 2015-03-19 イエール ユニバーシティ Ｅ３ユビキチンリガーゼによる標的タンパク質および他のポリペプチドの分解増強のための化合物および方法
GB201311891D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compound
GB201311888D0 (en) 2013-07-03 2013-08-14 Glaxosmithkline Ip Dev Ltd Novel compounds
US20180228907A1 (en) 2014-04-14 2018-08-16 Arvinas, Inc. Cereblon ligands and bifunctional compounds comprising the same
AU2016349781A1 (en) 2015-11-02 2018-05-10 Yale University Proteolysis targeting chimera compounds and methods of preparing and using same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0428000A1 (en) 1989-11-03 1991-05-22 Abbott Laboratories Fluorogenic substrates for the detection of proteolytic enzyme activity
US5011910A (en) * 1989-12-28 1991-04-30 Washington University Reagent and method for determining activity of retroviral protease
US5164300A (en) 1989-12-28 1992-11-17 Washington University Method for determining activity of retroviral protease
DK93990D0 (da) * 1990-04-17 1990-04-17 Carlsberg As Fluorogene peptider og deres anvendelse ved bestemmelse af enzymatisk aktivitet
HU9201687D0 (en) 1992-05-21 1992-08-28 Arpad Furka Preparation of sets from peptid mixtures with polycomponents and their use for the identification of biologically active peptides
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
ATE160223T1 (de) 1993-12-15 1997-11-15 Combichem Inc Kombinatorische bibliotheken und verfahren zu ihrer verwendung
US5506115A (en) 1994-04-29 1996-04-09 G. D. Searle & Co. Reagent and method for determining activity of herpes protease
US5738996A (en) * 1994-06-15 1998-04-14 Pence, Inc. Combinational library composition and method
DE69725901T2 (de) 1996-01-04 2004-09-09 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Methode zur bestimmung von proteolytischen enzymen unter benutzung von fluoreszenzgelöschten substraten
US7135288B2 (en) * 2002-09-27 2006-11-14 Ut-Battelle, Llc Combinatorial synthesis of ceramic materials

Also Published As

Publication number Publication date
AU2645097A (en) 1997-11-26
US6528275B1 (en) 2003-03-04
AU2644997A (en) 1997-11-12
DE69705838D1 (de) 2001-08-30
WO1997040065A3 (en) 1997-12-04
CA2252508A1 (en) 1997-10-30
ATE203545T1 (de) 2001-08-15
EP0906333A2 (en) 1999-04-07
EP0906333B1 (en) 2001-07-25
AU706855B2 (en) 1999-06-24
JP4215822B2 (ja) 2009-01-28
CA2252408A1 (en) 1997-11-13
JP2001501170A (ja) 2001-01-30
DK0906333T3 (da) 2001-11-12
JP2000512979A (ja) 2000-10-03
US20030092067A1 (en) 2003-05-15
EP0906334A1 (en) 1999-04-07
WO1997040065A2 (en) 1997-10-30
DE69705838T2 (de) 2002-04-11
WO1997042216A1 (en) 1997-11-13
ES2162277T3 (es) 2001-12-16

Similar Documents

Publication Publication Date Title
CA2252408A1 (en) Auto-deconvoluting combinatorial libraries
Appelt Crystal structures of HIV-1 protease-inhibitor complexes
Beck et al. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development
Dolle Discovery of enzyme inhibitors through combinatorial chemistry
Abbenante et al. Regioselective structural and functional mimicry of peptides. Design of hydrolytically-stable cyclic peptidomimetic inhibitors of HIV-1 protease.
JPH09501490A (ja) 位相学的に分離された、コードされた固相ライブラリー
US7417024B2 (en) Template-fixed peptidomimetics as inhibitors of serine proteases
Al-Obeidi et al. Peptide and peptidomimetic libraries: molecular diversity and drug design
HU221730B1 (hu) Eljárás nagy aktivitású peptideket tartalmazó peptidkeverékek előállítására
AU2013409231B2 (en) Beta-Hairpin peptidomimetics as selective elastase inhibitors
EP1856140B1 (en) Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
Groth et al. PEG based resins for protease drug discovery synthesis, screening and analysis of combinatorial on-bead libraries
Rinnová et al. A picomolar inhibitor of resistant strains of human immunodeficiency virus protease identified by a combinatorial approach
AU775164B2 (en) Methods and reagents for determining enzyme substrate specificity, and uses related thereto
Metcalf III et al. Src homology-2 domains and structure-based, small-molecule library approaches to drug discovery
AU740480B2 (en) A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
PETTEWAY JR Design of Peptide Analog Inhibitors
Hui et al. Model peptides to study the effects of P2 and P3 substitutions in statine‐containing HIV proteinase inhibitors
JP3362178B2 (ja) 新規ペプチド及びそれを含有するエイズウイルス（ｈｉｖ−１）プロテアーゼ阻害剤
Biagini et al. Analogue and Conformational Studies on Peptides, Hormones and Other Biologically
JP2004505991A (ja) Ｌａｔペプチドおよび免疫抑制剤を同定するためのアッセイにおけるそれらの使用
Solanas et al. Synthesis and biological activity of gramicidin S analogues containing constrained phenylalanines
HK1117541B (en) Template-fixed peptidomimeticsas inhibitors of serine proteases

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ON=MEDIVIR UK LTD; FT=THE FORMER OWNER WAS: PEPTID